Literature DB >> 29911510

Mixed adenoneuroendocrine carcinoma of the colon and rectum.

S Qiu1, G Pellino2, O J Warren1, S Mills1, R Goldin3, C Kontovounisios1,2, P P Tekkis1,2.   

Abstract

Mixed adenoneuroendocrine carcinoma (MANEC) are rare cancers of the gastrointestinal (GI) and pancreatobiliary tract. They are characterized by the presence of a combination of epithelial and neuroendocrine elements, where each component represents at least 30% of the tumour. Review of literature and consolidation of clinicopathological data. Sixty-one cases of colorectal MANEC have been reported in literature and one seen in this centre. The median age of the patients affected was 61.9 ± 12.4 years (20-94 years). Male to female ratio is 1.0:1.2. Presentations were similar to other colorectal malignancies. 58.0% of colorectal MANECs were found in the right colon, 8.1% cases in the transverse, 16.1% in the left colon, 16.1% in the rectum. These tumours appeared invasiveness 79.1% were T3-T4. Over 90% of cases were presented with metastatic disease. The majority of patient underwent surgical resection of the primary cancer (96.6%). Of these, 10 operations (17.9%) were emergency operations due to obstruction, perforation, or bleeding. Three patients received first line palliative care. In eight cases (13.8%), patients underwent adjuvant chemotherapy. The median overall survival after diagnosis was 10 ± 2.4 months (95% CI: 5.37-14.64 months). MANECs are rare but aggressive colorectal cancers. Surgical resection of localized disease with adjuvant chemotherapy appears to significantly improve survival in small case series. Further understanding through the sharing of experiences is required.

Entities:  

Keywords:  Mixed adenoneuroendocrine carcinoma (MANEC)

Mesh:

Year:  2018        PMID: 29911510     DOI: 10.1080/00015458.2018.1482697

Source DB:  PubMed          Journal:  Acta Chir Belg        ISSN: 0001-5458            Impact factor:   1.090


  6 in total

Review 1.  An Update on the Management of Mixed Neuroendocrine-Non-neuroendocrine Neoplasms (MiNEN).

Authors:  Aasems Jacob; Rishi Raj; Derek B Allison; Heloisa P Soares; Aman Chauhan
Journal:  Curr Treat Options Oncol       Date:  2022-03-26

2.  Perforated High-Grade Mixed Neuroendocrine Nonneuroendocrine Neoplasm of Cecum: Unusual Presentation of Rare Disease.

Authors:  Gunasekaran Gopalakrishnan; Bheemanathi Hanuman Srinivas; Biju Pottakkat; Senthil Gnanasekaran; Raja Kalayarasan
Journal:  Gastrointest Tumors       Date:  2021-04-20

Review 3.  Colorectal neuroendocrine carcinoma: A case report and review of the literature.

Authors:  Tomoaki Yoshida; Kenya Kamimura; Kazunori Hosaka; Koji Doumori; Hiromitsu Oka; Akito Sato; Yasuo Fukuhara; Shoji Watanabe; Tomomi Sato; Akira Yoshikawa; Takashi Tomidokoro; Shuji Terai
Journal:  World J Clin Cases       Date:  2019-07-26       Impact factor: 1.337

4.  Clinicopathological features and prognostic factors associated with gastroenteropancreatic mixed neuroendocrine non-neuroendocrine neoplasms in Chinese patients.

Authors:  Yu-Chen Huang; Ning-Ning Yang; Hong-Chun Chen; Yuan-Li Huang; Wen-Tian Yan; Ru-Xue Yang; Nan Li; Shan Zhang; Pan-Pan Yang; Zhen-Zhong Feng
Journal:  World J Gastroenterol       Date:  2021-02-21       Impact factor: 5.742

5.  A Rare Collision Tumor: Adenocarcinoma in the Ampulla of Vater and Neuroendocrine Tumor in the Lower Part of the Common Bile Duct.

Authors:  Mitsuhiro Tachibana; Kazuyasu Kamimura; Kei Tsukamoto; Yutaka Tsutsumi
Journal:  Cureus       Date:  2021-06-24

6.  Mixed epithelial endocrine neoplasms of the colon and rectum - An evolution over time: A systematic review.

Authors:  Rani Kanthan; Suresh Tharmaradinam; Tehmina Asif; Shahid Ahmed; Selliah C Kanthan
Journal:  World J Gastroenterol       Date:  2020-09-14       Impact factor: 5.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.